No clarity on FDI in biotech, say experts
Foreign direct investment (FDI) and regulatory issues in clinical trial processes in the biotech industry need more clarity. Also, considering the capital-intensive needs of the biotech industry, the
Foreign direct investment (FDI) and regulatory issues in clinical trial processes in the biotech industry need more clarity. Also, considering the capital-intensive needs of the biotech industry, the